Navigation Links
Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
Date:4/24/2013

SAN DIEGO, April 24, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Needham 12th Annual Healthcare Conference in New York City.  

The live presentation takes place on Wednesday, May 1 at 9:20 a.m. Eastern Time / 6:20 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for one month.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
2. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
3. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
4. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
5. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
6. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
7. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
8. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
10. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
11. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... report is available in its catalogue: ... and Technologies for Advanced Drug Delivery ... Administration http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)...  Luminex Corporation (Nasdaq: LMNX ) today announced that ... 2013 on Monday, February 3, 2014. A press release announcing ... trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... highlights and financial results for the fourth quarter and twelve ...
(Date:1/14/2014)... /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System - a ... to place and insert the screw accurately - offers ... ligament) repair or reconstruction as it holds the bones ... http://photos.prnewswire.com/prnh/20140114/MN45636 ) The SLIC Screw ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... new recommendation from the U.S. Preventive Services Task Force (USPSTF) ... attacks and strokes among many adults, the head of Partnership ... reduces first heart attacks in men and first strokes in ... of 45 and 79 and to women 55 to 79. ...
... Eastern Time - SOUTH SAN FRANCISCO, Calif., March 16 ... a biopharmaceutical company focused on oncology, today reported financial ... 31, 2008, and provided a corporate update. "During the ... our goal of developing picoplatin as an oncology platform ...
Cached Medicine Technology:New Aspirin Recommendation Can Help Prevent Heart Attacks & Strokes, Says Partnership for Prevention 2Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 9
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... at the University of California, San Diego School of ... who have suffered a recent major loss are more ... adults. , The study is published in this month,s ... . , Because compassionate behaviors are associated with better ... offer insights into ways to improve the outcomes of ...
(Date:4/17/2014)... Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, was ... April issue of Nature Reviews Microbiology , ... Dr. McCullers, a world-renowned infectious disease specialist, and ... University of Tennessee Health Science Center, analyzed the ... 1957 and 1968 pandemics, as well as more ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
(Date:4/17/2014)... one in five infants in the United States annually ... several months after birth. Research into probiotic use for ... April 1, 2014 issue of the British Medical ... "Probiotics and Infant Colic," concluding that the use of ... did not reduce crying or fussing in infants ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... new study published in the American Journal of Clinical Nutrition, ... milk nutrients, calcium and vitamin D, may do more than ... cancer in women by at least 60 percent. ... over the age of 55 in one of three supplement ...
... are in hospital with flu symptoms after an outbreak of ... minister said Friday. The five, aged between 11 months ... live within 300 metres (328 yards) of the outbreak -- ... outskirts of the capital. "They went to the hospital to ...
... APEC health ministers agreed Friday to share samples of the ... aside disputes over who "owns" the disease. The 21-nation group ... committing them to share samples of the H5N1 virus, which ... since 2003. ,Indonesia refused to share bird flu ...
... dead magpie has tested positive for the deadly H5N1 bird ... said laboratory tests had confirmed that the bird, found ... infected with the killer strain. ,They warned of ... the 17th wild bird that has been found dead in ...
... the idea of implanting tiny electronic hearing devices in ... alternative that promised superior results was implanting a ... however, scientists have shown in animals that its possible ... auditory nerve that can successfully transmit a wide range ...
... it? Did you clean out your medicine cabinet? Before ... be taken . ,There is increasing evidence ... all the medications get removed by sewage treatment systems, ... at University of the Sciences in Philadelphia. There is ...
Cached Medicine News:Health News:Milk Nutrients may Keep Cancer at Bay. 2Health News:APEC Agree to Share Bird Flu Samples 2Health News:Radical Idea of Implanting Tiny Electrodes to the Deaf 2Health News:Radical Idea of Implanting Tiny Electrodes to the Deaf 3Health News:Take Precautions Before You Clean Out Your Medicine Cabinet 2
... plus Neu Thera is ... alcohol hand sanitizer that ... of the Neu-Thera technology. ... clinically proven to be ...
Exidine® 2% CHG Brushless Surgical Scrub offers exceptional persistence and broad-spectrum antimicrobial activity....
... FDA approved, Avagard antiseptic hand prep ... hand scrub brushes and antimicrobial soaps. ... hands for surgery, it's fast-acting and ... for up to six hours without ...
... cleanser will not leave your hands dry, ... With persistent Antimicrobial action, CHG Skin Cleanser ... gram-negative and gram-positive bacteria, fungi, and yeasts. ... second hand wash. The solution does not ...
Medicine Products: